234 related articles for article (PubMed ID: 2019836)
1. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.
Twijnstra A; van Zanten AP; Nooyen WJ; Ongerboer de Visser BW
J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216
[TBL] [Abstract][Full Text] [Related]
3. Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.
Twijnstra A; Ongerboer de Visser BW; van Zanten AP; Hart AA; Nooyen WJ
J Neurooncol; 1989 May; 7(1):57-63. PubMed ID: 2666594
[TBL] [Abstract][Full Text] [Related]
4. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
[TBL] [Abstract][Full Text] [Related]
5. Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancer.
Fleisher M; Wasserstrom WR; Schold SC; Schwartz MK; Posner JB
Cancer; 1981 Jun; 47(11):2654-9. PubMed ID: 7260857
[TBL] [Abstract][Full Text] [Related]
6. Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.
Twijnstra A; van Zanten AP; Hart AA; Ongerboer de Visser BW
J Neurol Neurosurg Psychiatry; 1987 Mar; 50(3):313-20. PubMed ID: 3559613
[TBL] [Abstract][Full Text] [Related]
7. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Glantz MJ
Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
[TBL] [Abstract][Full Text] [Related]
8. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.
Wasserstrom WR; Glass JP; Posner JB
Cancer; 1982 Feb; 49(4):759-72. PubMed ID: 6895713
[TBL] [Abstract][Full Text] [Related]
10. Tumour markers in the cerebrospinal fluid of patients with central nervous system metastases from extracranial malignancies.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; Hart AA; Nooyen WJ
Clin Chim Acta; 1988 Jul; 175(2):157-66. PubMed ID: 3409530
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biochemical markers of central nervous system metastases.
Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid beta 2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseases.
Twijnstra A; van Zanten AP; Nooyen WJ; Hart AA; Ongerboer de Visser BW
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):387-91. PubMed ID: 3525181
[TBL] [Abstract][Full Text] [Related]
13. HMFG1 antigen: a new marker for carcinomatous meningitis.
Moseley RP; Oge K; Shafqat S; Moseley CM; Sullivan NM; Badley RA; Burchell J; Taylor-Papadimitriou J; Coakham HB
Int J Cancer; 1989 Sep; 44(3):440-4. PubMed ID: 2777410
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases.
van Zanten AP; Twijnstra A; van Benthem V; Hart AA; Ongerboer de Visser BW
Clin Chim Acta; 1985 Apr; 147(2):127-34. PubMed ID: 3987058
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
[TBL] [Abstract][Full Text] [Related]
16. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.
Jacobi C; Reiber H; Felgenhauer K
J Neurol; 1986 Nov; 233(6):358-61. PubMed ID: 3806144
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
[TBL] [Abstract][Full Text] [Related]
18. Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: a pilot study in 13 patients.
Nakagawa H; Fujita T; Kubo S; Izumoto S; Nakajima Y; Tsuruzono K; Tokiyoshi K; Hayakawa T
Surg Neurol; 1996 Mar; 45(3):256-64. PubMed ID: 8638223
[TBL] [Abstract][Full Text] [Related]
19. Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer.
Ino R; Sada KE; Miyauchi A; Hashimoto D; Nojima S; Yamanaka S; Kawamura M
Acta Med Okayama; 2021; 75(5):659-661. PubMed ID: 34703051
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid tumor markers for the diagnosis and management of leptomeningeal metastases.
Malkin MG; Posner JB
Eur J Cancer Clin Oncol; 1987 Jan; 23(1):1-4. PubMed ID: 3297711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
